Allele-specific MMP-3 Transcription Under in Vivo Conditions
Overview
Affiliations
A common matrix metalloproteinases-3 (MMP-3) -1612 5A/6A promoter polymorphism is associated with risk for cardiovascular disease, rheumatoid arthritis, and other diseases. Here we used the haplotype chromatin immunoprecipitation method to study allele-specific MMP-3 expression under in vivo conditions in heterozygous THP-1 cells. Pyrosequencing was used to analyse the ratio of 5A-allele to 6A-allele after chromatin immunoprecipitation using an antibody against phosphorylated active RNA polymerase II. There was no allele-specific difference in transcriptional activity during basal conditions, i.e., in unstimulated monocytic THP-1 cells. However, after stimulation of MMP-3 expression by monocyte differentiation or incubation with IL-1beta, the haplotype containing the 5A-allele was associated with higher transcriptional activity compared with the 6A-containing haplotype. Electromobility shift assay demonstrated increased binding of nuclear proteins to the 5A-allele after monocyte differentiation. In conclusion, the common MMP-3 5A/6A promoter polymorphism appears to be functional only during specific environmental conditions involving inflammation.
Djuric T, Kuveljic J, Djordjevic A, Dekleva M, Stankovic G, Stankovic A Mol Genet Genomic Med. 2022; 10(9):e2022.
PMID: 35912721 PMC: 9482398. DOI: 10.1002/mgg3.2022.
Genetic Variants of Matrix Metalloproteinase and Sepsis: The Need Speed Study.
Fiotti N, Mearelli F, Di Girolamo F, Castello L, Nunnari A, Di Somma S Biomolecules. 2022; 12(2).
PMID: 35204780 PMC: 8961575. DOI: 10.3390/biom12020279.
Lu Y, Ussher N, Zhou Y, Jelinek H, Hambly B, Li A J Pers Med. 2021; 11(8).
PMID: 34442348 PMC: 8399546. DOI: 10.3390/jpm11080705.
Qi Y, Wang J, Sun M, Ma C, Jin T, Liu Y Mol Genet Genomic Med. 2018; 7(2):e00519.
PMID: 30548828 PMC: 6393650. DOI: 10.1002/mgg3.519.
Association between polymorphisms among Chinese patients with osteonecrosis of the femoral head.
Qi Y, Zhu Y, Cao Y, Wu H, Sun M, Wu H Oncotarget. 2018; 8(65):108859-108866.
PMID: 29312574 PMC: 5752487. DOI: 10.18632/oncotarget.22313.